MySize, an Israeli retail technology provider, has closed a $2.5 million private placement agreement to avert an impending cash shortage. The Nasdaq-listed company signed final terms for the sale of 1,308,901 common shares at a price of $1.91 per share, utilizing H.C. Wainwright & Co. as its exclusive placement agent.
Investors participating in this round will also receive Series C and Series D warrants. Each series covers up to 1,308,901 additional shares at an exercise price of $1.66. The Series C warrants have a five-year term, while the Series D warrants are valid for 18 months after the effective date of the resale registration.
The deal is scheduled to close around September 16, 2026. This funding arrived in time, as MySize reported a modest cash balance of $453,000 as of June 30, 2026, highlighting an urgent need for new capital. The gross proceeds of $2.5 million immediately bridge this financial gap and provide necessary operational runway.
Beyond covering immediate working capital needs, MySize intends to direct the net proceeds toward broader corporate reorganization. The company currently operates in technology and commerce sectors, encompassing areas such as sizing, e-commerce, second-hand fashion, and brand distribution. Management plans to use the fresh capital to pursue selective acquisitions aimed at entering the defense technology sector.
However, this transaction comes with conditions for existing stakeholders. The issuance of over 1.3 million new shares along with two large series of warrants creates immediate dilution risks. If these warrants are exercised, current ownership stakes will be significantly reduced. For now, market pricing in accordance with Nasdaq rules gives MySize a chance to execute its strategic operational transition.